Generated by AI
AngioDynamics Inc. is a medical technology company that develops, manufactures, and markets minimally invasive medical devices for healthcare providers. Its product portfolio supports image-guided procedures across vascular intervention, vascular access, oncology, and surgical care, with devices used to treat peripheral vascular disease and other non-coronary conditions. The company offers a broad range of therapeutic and diagnostic products, including atherectomy systems, venous therapies, ablation technologies, fluid management tools, dialysis access products, drainage devices, and angiographic accessories. AngioDynamics serves hospitals, health systems, ambulatory procedure sites, and specialist physicians, primarily in the United States, with additional international sales through distributors and direct channels. Headquartered in Latham, New York, AngioDynamics plays a specialized role in the medical device market by providing tools designed for minimally invasive treatment and procedural precision.
Website14 Plaza Drive
Latham, NY, 12110
United States
The latest articles about ANGO.
LATHAM, N.Y., November 06, 2026--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the grant of inducement awards to Eric Honroth in connection with his appointment as Chief Executive Officer of the Company effective as of November 2, 2026.
Summary of Oct 16's posts. Generated by AI.
Summary of Jan 6's posts. Generated by AI.
Summary of Jan 6's posts. Generated by AI.
Summary of Oct 16's posts. Generated by AI.
Investors talking about ANGO also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.